HealthQuill India
The US, the world’s second-largest greenhouse gas emitter in the world, will withdraw from a global pact to limit global warming.
Climate Health Medical

US to pull out from Paris Agreement that limits global warming 

The US, the world’s second-largest greenhouse gas emitter in the world, will withdraw from a global pact to limit global warming.

Read More
Negotiators at a global climate conference signed a $300 billion-a-year deal to finance emissions reduction — that developing nations say falls way short of their expectations.
Climate Health Pharma

Global warming on backburner; vexed financing deal sees light at COP29 

Global representatives at a climate conference signed a $300 billion-a-year deal to finance emissions reductions — a move developing nations say falls way.

Read More
GLP-1 based weight-loss drugs have some therapeutic benefits, but the risks are as high
Drugs Health Pharma

Global diabetic population rose fourfold to 828 million in 2022

The global diabetic population has risen fourfold to 828 million during the last three decades, with more than a quarter living in India,.

Read More
Tuberculosis has emerged as the world’s top infectious disease with about 8.2 million people newly diagnosed with the illness last year — the highest on records since WHO began global monitoring in 1995.
Drugs Health Medical

Tuberculosis was the world’s top infectious disease killer last year

Tuberculosis has emerged as the world’s top infectious disease with about 8.2 million people newly diagnosed with the illness last year — the.

Read More
In a small region in India’s technology capital of Bengaluru, social activists, despite initial hesitation from its urban poor, walked into Anjanapura and completed one of the country’s first short-term engagements to impart the skills to fight climate change.
Climate Health Pharma Research

A social project to fight climate change in India begins to yield results

In a small region in India’s technology capital of Bengaluru, social activists, despite initial hesitation from its urban poor, walked into Anjanapura and.

Read More
India’s coronary drug-eluting stent market may grow at a compound annual growth rate of 4% until 2033 on the back of a rise in coronary artery diseases, according to UK-based data analytics and consulting company, GlobalData.
Drugs Medical Pharma

Coronary drug-eluting stent market to grow 4% in India till 2033: Report

India’s coronary drug-eluting stent market may grow at a compound annual growth rate of 4% until 2033 on the back of a rise.

Read More
Glaciers suffered the largest mass loss in 50 years as last year marked the driest for global rivers in 33 years, according to a World Meteorological Organization report.
Climate Health Pharma

Global glaciers suffer largest mass loss in 50 yrs, 2023 driest for rivers

Glaciers suffered the largest mass loss in 50 years as last year marked the driest for global rivers in 33 years, according to.

Read More
A global goal to reduce methane emissions “ seems as distant as a desert oasis” now, as about two-thirds of it comes from human activities such as fossil fuels, agriculture and landfills, researchers find.
Climate Health Pharma

Global goal to cut methane emissions as distant as a ‘desert oasis’

A global goal to reduce methane emissions “ seems as distant as a desert oasis” now, as about two-thirds of it comes from.

Read More
India suspects a young male to be infected with mpox after he travelled to a country currently in the grip of the disease, according to a government statement.
Drugs Health Pharma

Young Indian male suspected to have mpox disease, contact tracing on

India suspects a young male to be infected with mpox after he travelled to a country currently in the grip of the disease,.

Read More
India’s Mankind Pharma will buy Mumbai-based Bharat Serums and Vaccines for 136 billion rupees ($1.63 billion), according to a company statement.
Drugs Health Pharma

Mankind Pharma buys Bharat Serum and Vaccines for $1.6 billion

India’s Mankind Pharma will buy Mumbai-based Bharat Serums and Vaccines for 136 billion rupees ($1.63 billion), according to a company statement.

Read More